0001947620-25-000003.txt : 20250805
0001947620-25-000003.hdr.sgml : 20250805
20250805133143
ACCESSION NUMBER: 0001947620-25-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
FILED AS OF DATE: 20250805
DATE AS OF CHANGE: 20250805
EFFECTIVENESS DATE: 20250805
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lapix Therapeutics Inc.
CENTRAL INDEX KEY: 0001947620
ORGANIZATION NAME:
EIN: 842410144
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-553733
FILM NUMBER: 251184082
BUSINESS ADDRESS:
STREET 1: 75 KNEELAND STREET
STREET 2: 14TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02111
BUSINESS PHONE: 1 (617) 766-3909
MAIL ADDRESS:
STREET 1: 75 KNEELAND STREET
STREET 2: 14TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02111
D
1
primary_doc.xml
X0708
D
LIVE
0001947620
Lapix Therapeutics Inc.
271 Cambridge St., 2nd Floor
Cambridge
MA
MASSACHUSETTS
02141
8582264717
DELAWARE
None
None
Corporation
true
Anas
Fathallah
c/o Lapix Therapeutics, Inc.
271 Cambridge St., 2nd Floor
Cambridge
MA
MASSACHUSETTS
02141
Executive Officer
Director
President and Secretary
Jason
Norris
c/o Lapix Therapeutics, Inc.
271 Cambridge St., 2nd Floor
Cambridge
MA
MASSACHUSETTS
02141
Executive Officer
Director
Vice President and Treasurer
Henry
McKinnell
c/o Lapix Therapeutics, Inc.
271 Cambridge St., 2nd Floor
Cambridge
MA
MASSACHUSETTS
02141
Director
Francisco
Leon
c/o Lapix Therapeutics, Inc.
271 Cambridge St., 2nd Floor
Cambridge
MA
MASSACHUSETTS
02141
Director
Anthony
Gibney
c/o Lapix Therapeutics, Inc.
271 Cambridge St., 2nd Floor
Cambridge
MA
MASSACHUSETTS
02141
Director
Other Technology
Decline to Disclose
- 06b
false
2025-07-21
false
true
Simple Agreement for Future Equity
false
1000
5000000
2200000
2800000
false
10
0
true
0
true
0
true
false
Lapix Therapeutics Inc.
/s/ Ana Fathallah
Anas Fathallah
President
2025-08-05